181 related articles for article (PubMed ID: 36624687)
1. A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma.
Hashemi SMA; Moradi A; Hosseini SY; Razavi Nikoo H; Bamdad T; Faghih Z; Sarvari J; Tabarraei A
Iran Biomed J; 2023 Jan; 27(1):34-45. PubMed ID: 36624687
[TBL] [Abstract][Full Text] [Related]
2. EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line.
Hashemi SMA; Moradi A; Hosseini SY; Razavi Nikoo H; Bamdad T; Razmkhah M; Sarvari J; Tabarraei A
Rep Biochem Mol Biol; 2023 Jan; 11(4):672-683. PubMed ID: 37131894
[TBL] [Abstract][Full Text] [Related]
3. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.
Saridakis V; Sheng Y; Sarkari F; Holowaty MN; Shire K; Nguyen T; Zhang RG; Liao J; Lee W; Edwards AM; Arrowsmith CH; Frappier L
Mol Cell; 2005 Apr; 18(1):25-36. PubMed ID: 15808506
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
5. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF
Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
[TBL] [Abstract][Full Text] [Related]
6. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.
Holowaty MN; Zeghouf M; Wu H; Tellam J; Athanasopoulos V; Greenblatt J; Frappier L
J Biol Chem; 2003 Aug; 278(32):29987-94. PubMed ID: 12783858
[TBL] [Abstract][Full Text] [Related]
7. HAUSP/USP7 as an Epstein-Barr virus target.
Holowaty MN; Frappier L
Biochem Soc Trans; 2004 Nov; 32(Pt 5):731-2. PubMed ID: 15494000
[TBL] [Abstract][Full Text] [Related]
8. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
10. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
[TBL] [Abstract][Full Text] [Related]
11. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
Holowaty MN; Sheng Y; Nguyen T; Arrowsmith C; Frappier L
J Biol Chem; 2003 Nov; 278(48):47753-61. PubMed ID: 14506283
[TBL] [Abstract][Full Text] [Related]
12. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
AlQarni S; Al-Sheikh Y; Campbell D; Drotar M; Hannigan A; Boyle S; Herzyk P; Kossenkov A; Armfield K; Jamieson L; Bailo M; Lieberman PM; Tsimbouri P; Wilson JB
Oncogene; 2018 Jul; 37(29):3998-4012. PubMed ID: 29691476
[TBL] [Abstract][Full Text] [Related]
13. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
[TBL] [Abstract][Full Text] [Related]
14. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity.
He Y; Li W; Lv D; Zhang X; Zhang X; Ortiz YT; Budamagunta V; Campisi J; Zheng G; Zhou D
Aging Cell; 2020 Mar; 19(3):e13117. PubMed ID: 32064756
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
Sivachandran N; Cao JY; Frappier L
J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
[TBL] [Abstract][Full Text] [Related]
17. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
18. Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
Heessen S; Leonchiks A; Issaeva N; Sharipo A; Selivanova G; Masucci MG; Dantuma NP
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1532-7. PubMed ID: 11805282
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.
Yang H; Zheng Z; Zhao LY; Li Q; Liao D
Cell Cycle; 2012 Feb; 11(3):582-93. PubMed ID: 22262167
[TBL] [Abstract][Full Text] [Related]
20. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
